Nachrichten zur Infinity Pharmaceuticals Inc. Aktie

Pancreatic Cancer Market revenue to reach USD 36 Billion by 2036, says Research Nester

Key pancreatic cancer market players include Amgen Inc., Novartis AG, Pfizer Inc., Aduro Biotech Inc., Clovis Oncology Inc., NewLink Genetics…

Infinity Pharmaceuticals, Inc. : Please contact the Portnoy Law Firm to recover your losses; October 16, 2023, deadline.

Investors can contact the law firm at no cost to learn more about recovering their losses…

INFI MONDAY DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities Class Action – INFI

NEW YORK, Oct. 13, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

INFINITY ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Infinity Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

NEW YORK, Oct. 08, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…

INFI IMPORTANT DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important October 16 Deadline in Securities Class Action – INFI

NEW YORK, Oct. 08, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Infinity Pharmaceuticals, Inc. Investors: Lead Plaintiff Deadline is Approaching in the Class Action Against Infinity Pharmaceuticals, Inc.; Contact Robbins LLP Today

Infinity Pharmaceuticals, Inc. (INFI) Misled Investors Regarding its Business Prospects…

Infinity Pharmaceuticals, Inc. : Please contact the Portnoy Law Firm to recover your losses; October 16, 2023, deadline

Investors can contact the law firm at no cost to learn more about recovering their losses…

ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities Class Action – INFI

NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Infinity Pharmaceuticals, Inc. - INFI

NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Applied Digital, Infinity, and Shift4 and Encourages Investors to Contact the Firm

NEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Lead Plaintiff Deadline Approaching: Infinity Pharmaceuticals, Inc. Investors Should Contact Robbins LLP for Information About the Infinity Pharmaceuticals, Inc. Class Action

Infinity Pharmaceuticals, Inc. (INFI) Misled Investors Regarding its Business Prospects…

Infinity Pharmaceuticals reportedly files for Chapter 11

…

ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – INFI

NEW YORK, Sept. 28, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Live Nation, Applied Digital, and Infinity and Encourages Investors to Contact the Firm

NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – INFI

NEW YORK, Sept. 22, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Infinity, Shift4, and Comerica and Encourages Investors to Contact the Firm

NEW YORK, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Infinity Pharmaceuticals receives delisting determination letter from Nasdaq

…

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INFI

NEW YORK, Sept. 12, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bausch, Applied Digital, and Infinity and Encourages Investors to Contact the Firm

NEW YORK, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Infinity Pharmaceuticals, Inc. - INFI

NEW YORK, Sept. 10, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…

Form 8-K INFINITY PHARMACEUTICALS For: Jul 24

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Infinity Pharma Shares Drop 43% After Ending Merger Deal With MEI Pharma

Infinity Pharma Shares Drop 43% After Ending Merger Deal With MEI Pharma...…

Infinity Pharmaceuticals Ends Merger Agreement With MEI Pharma

Infinity Pharmaceuticals Ends Merger Agreement With MEI Pharma...…

Infinity Pharmaceuticals stock plummets on terminating merger agreement with MEI Pharma

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K INFINITY PHARMACEUTICALS For: Jul 23

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K INFINITY PHARMACEUTICALS For: Jul 14

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Infinity Pharma (INFI) Stock Up on Advancing Cancer Study

Infinity Pharma (INFI) provides insights on the phase II MARIO-8 study design. The study will evaluate eganelisib for squamous cell…

Form 8-K INFINITY PHARMACEUTICALS For: Jul 03

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K INFINITY PHARMACEUTICALS For: Jun 27

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K INFINITY PHARMACEUTICALS For: Jun 15

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 10-Q INFINITY PHARMACEUTICALS For: Mar 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K INFINITY PHARMACEUTICALS For: Apr 04

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K INFINITY PHARMACEUTICALS For: Mar 28

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 10-K INFINITY PHARMACEUTICALS For: Dec 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Will Infinity Pharmaceuticals (INFI) Report Negative Q4 Earnings? What You Should Know

Infinity (INFI) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

XFRA : I3F: Wiederaufnahme/Resumption

FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE. THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING…

Form 8-K INFINITY PHARMACEUTICALS For: Feb 22

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Infinity Pharmaceuticals, Inc. (INFI)

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - February 23, 2023) - Law office of Brodsky & Smith announces that it is investigating…

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Infinity Pharmaceuticals, Inc. Merger

Wilmington, Delaware--(Newsfile Corp. - February 23, 2023) - Rigrodsky Law, P.A. is investigating Infinity Pharmaceuticals, Inc. ("Infinity") (NASDAQ: INFI) regarding…

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Infinity Pharmaceuticals, Inc.

NEW YORK, Feb. 23, 2023 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Infinity Pharmaceuticals, Inc.…

Shareholder Alert: Ademi LLP investigates whether Infinity Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with MEI Pharma

MILWAUKEE, Feb. 23, 2023 /PRNewswire/ -- Ademi LLP is investigating Infinity (NASDAQ: INFI) for possible breaches of fiduciary duty and…

dpa-AFX ProFeed